December 7-10, 2013, New Orleans - Researchers from the Bing Center for WM attended the 2013 Annual ASH Meeting and Exposition, which was held at the Morial Convention Center. There they presented 5 posters including continued findings from the first whole genome sequencing project for WM, and continuing investigations into the MYD88 signaling pathway, L265P Mutation, CXCR4 and its effects on Ibrutinib, and a multi-center study of RAD001.

Read the latest press releases on the Bing Center's latest discoveries regarding Ibrutinib and clinical trials:

http://online.wsj.com/article/PR-CO-20131210-910262.html?dsk=y

http://ca.finance.yahoo.com/news/pharmacyclics-announces-data-presentations-ibrutinib-221900220.html

http://www.onclive.com/conference-coverage/ash-2013/Ibrutinib-Induces-Rapid-Durable-Responses--in-Waldenstrms-Macroglobulinemia

For more information about the American Society of Hematology (ASH) annual meeting and exposition, please visit their website at http://www.hematology.org/.

Watch the webcast of the ASH 2013 Review given on December 19, 2013 at the Dana-Farber Jimmy Fund Auditorium by Ann S. LaCasce. Included in her "Lymphoma Highlights" is a review of the oral presentation given by Dr. Steven Treon on Ibrutinib in Waldenstrom's Macroglobulinemia.

http://video.dfcionline.org/accordent/BMT121913

ASH 2013: Bing Center Poster Presentations

Click here to display photos of our ASH 2013 Attendees

Click the images to download the full-size posters as PDF files